BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pramipexole/ondansetron (ALTO-207) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Pramipexole/ondansetron (ALTO-207)\, from
  ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07553637-806@assetmemo.bio
DTSTAMP:20261121T005958Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Pramipexole/ondansetron (ALTO-207): Phase 2 readout est. (NCT075536
 37)
DESCRIPTION:Pramipexole/ondansetron (ALTO-207)\, phase 2\, Major Depressive
  Disorder.\nStudy: ALTO-207 in Adults With Treatment-resistant Depression 
 (TRD)\nEstimated primary completion: November 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/pramipexole-ondansetron-alto-207#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07553637
URL:https://assetmemo.bio/drug/pramipexole-ondansetron-alto-207#upcoming-ev
 ents
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
